Split Creek Capital’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$506K Sell
3,552
-239
-6% -$36.3K 0.48% 68
2026
Q2
$594K Buy
3,791
+102
+3% +$15.3K 0.55% 57
2026
Q1
$563K Sell
3,689
-75
-2% -$11.5K 0.59% 56
2025
Q4
$519K Buy
+3,764
New +$493K 0.55% 56

Other funds holding NVS

Split Creek Capital's NVS Position: Q3 2026 in Review

Split Creek Capital reduced its Novartis (NVS) stake by 6.3% in Q3 2026, selling an estimated $36.3K and leaving 3,552 shares worth $506K. The position accounts for 0.48% of the portfolio, ranked #68.

Split Creek Capital first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $594K in Q2 2026. 1,370 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Split Creek Capital held 3,552 shares of Novartis worth $506K as of Q3 2026.
  • Split Creek Capital sold 239 Novartis shares in Q3 2026, an estimated $36.3K.
  • Novartis made up 0.48% of Split Creek Capital's portfolio in Q3 2026, its #68 holding.
  • Split Creek Capital first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
  • Split Creek Capital's Novartis position peaked at $594K in Q2 2026.
  • 1,370 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Split Creek Capital's 13F filing for Q3 2026, filed 2 Nov 2026.